Mechanistic Determinants of Daprodustat Drug–Drug Interactions and Pharmacokinetics in Hepatic Dysfunction and Chronic Kidney Disease: Significance of OATP1B‐CYP2C8 Interplay

Ähnliche Einträge

• Navigating the Challenges of Cyclosporine as an Alternative to Rifampicin as an OATP1B Index Inhibitor
  von: Manthena V. S. Varma, et al.
  Veröffentlicht: (2025)
• Comprehensive Evaluation of OATP‐ and BCRP‐Mediated Drug–Drug Interactions of Methotrexate Using Physiologically‐Based Pharmacokinetic Modeling
  von: Sejung Hwang, et al.
  Veröffentlicht: (2024)
• Physiologically Based Pharmacokinetic Modeling to Investigate the Disease‐Drug–Drug Interactions between Voriconazole and Nirmatrelvir/Ritonavir in COVID‐19 Patients with CYP2C19 Phenotypes
  von: Peile Wang, et al.
  Veröffentlicht: (2024)
• Biomarker‐Based Prediction of OATP1B1 Activity in Clinical Routine—Investigating Coproporphyrins as Markers for Drug–Drug–Gene Interactions
  von: Leila Potzel, et al.
  Veröffentlicht: (2026)
• A Clinical Practice Perspective on the Evaluation of OATP1B1‐associated Drug Interactions
  von: Céline K. Stäuble, et al.
  Veröffentlicht: (2024)